Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Owlstone Medical

Explore full profile

Non-invasive breath biopsy platform for disease detection

Milton, United KingdomFounded 2004Biotech & Life Sciences
Valuation $250–500M Last recorded · 2025
Revenue $1–10M Latest reported FY
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Owlstone Medical and the history behind them.

About Owlstone Medical

Owlstone Medical is a health technology startup that operates in the medical diagnostics market. The company specializes in developing non-invasive diagnostic tests using breath biopsy technology. This technology analyzes volatile organic compounds (VOCs) in a patient's breath to detect diseases such as lung cancer at an early stage. The company's primary clients are healthcare providers and research organizations worldwide.

Read full description

Owlstone Medical's business model revolves around the development and sale of its breath biopsy products and services. The company offers a range of products for breath biopsy research, including the Breath Biopsy OMNI, an advanced solution for volatile metabolite analysis in breath, and the ReCIVA Breath Sampler, a tool for reliable and reproducible breath sample collection. These products are used in clinical trials and research labs to bring VOC biomarker research in-house.

In addition to selling products, Owlstone Medical also offers services such as OMED Health, a service that helps individuals manage their digestive health through at-home breath testing and professional analysis of exhaled gases. The company generates revenue through the sale of its products and services.

Owlstone Medical is making significant strides in the field of early disease detection, as demonstrated by their latest data on the development of a Breath Biopsy test for early detection of lung cancer. The company's innovative approach to medical diagnostics has the potential to revolutionize the healthcare industry by providing non-invasive, accurate, and early detection of various diseases.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2004
Headquarters
Milton, United Kingdom
Employees
148
Open positions
None listed
Dealroom signal
64.0/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Oncology, Remote Monitoring, Precision Medicine, Non-Invasive medical devices and treatments, Health Diagnostics, Spinout, Tech for Patients, uk is8 life sciences, UKSU
Business model
Manufacturing
Investment activity
1 company, latest Jan 2013
Capital deployed
$0
Preferred round
CORPORATE SPINOUT

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Oct 2025 $0 — Advanced Research Projects Agency for Health - ARPA-H ↗
GRANTOther financing Mar 2025 $2.3M — Cystic Fibrosis Foundation ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Owlstone Medical website traffic

Latest recorded traffic for Owlstone Medical is 9.5K monthly website visits, down 2.1% over the last three months. Owlstone Medical's team declined 12.4% over the past year.

Latest monthly visits9.5K 3-month web change-2.1% 1-year team growth-12.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

  • Cambridge University Entrepreneurs
  • X PRIZE Foundation
  • SBRI Healthcare
  • Bill & Melinda Gates Foundation
  • Cystic Fibrosis Foundation
  • Advanced Research Projects Agency for Health - ARPA-H

Series A1 investor entered at this stage

  • Vventures Investment

Series B and later4 investors entered at this stage

Other known investors1 additional known investor

  • University of Cambridge
Team profiled 22 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇬🇧 United Kingdom92.2%
🇺🇸 United States4.7%
🇳🇱 Netherlands0.8%
🇿🇦 South Africa0.8%
🇭🇰 Hong Kong0.8%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Owlstone Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Owlstone Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.